Works matching IS 20406207 AND DT 2021 AND VI 12

Results: 65

Current evidence and the emerging role of eltrombopag in severe aplastic anemia.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721998126

By:

Drexler, Beatrice;
Passweg, Jakob

Publication type:

Article

The evolving role of Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989588

By:

Gordon, Max J.;
Danilov, Alexey V.

Publication type:

Article

Cytomegalovirus prophylaxis using low-dose valganciclovir in patients with acute leukemia undergoing allogeneic hematopoietic stem-cell transplantation.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721998124

By:

Li, Po-Hsien;
Lin, Cheng-Hsien;
Lin, Yu-Hui;
Chen, Tsung-Chih;
Hsu, Chiann-Yi;
Teng, Chieh-Lin Jerry

Publication type:

Article

Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologist.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721996484

By:

Schmittlutz, Katrin;
Marks, Reinhard

Publication type:

Article

Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721994348

By:

Smith, Jasmine;
Kumar, Abhijeet;
Stanton, Natalie A.;
Katsanis, Emmanuel

Publication type:

Article

Case report: successful perioperative management of patients with haemophilia A using an extended half-life factor VIII (Efmoroctocog alfa) during neurosurgical procedures.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721993686

By:

Kocher, Florian;
Seeber, Andreas;
Kerschbaumer, Johannes;
Schmidt, Stefan;
Wolf, Dominik;
Feistritzer, Clemens

Publication type:

Article

The role of acalabrutinib in adults with chronic lymphocytic leukemia.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721990553

By:

Fakhri, Bita;
Andreadis, Charalambos

Publication type:

Article

Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721996488

By:

Franchi, Matteo;
Vener, Claudia;
Garau, Donatella;
Kirchmayer, Ursula;
Di Martino, Mirko;
Romero, Marilena;
De Carlo, Ilenia;
Scondotto, Salvatore;
Stival, Chiara;
Della Porta, Matteo Giovanni;
Passamonti, Francesco;
Corrao, Giovanni

Publication type:

Article

Current and novel BTK inhibitors in Waldenström's macroglobulinemia.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989586

By:

Ntanasis-Stathopoulos, Ioannis;
Gavriatopoulou, Maria;
Fotiou, Despina;
Dimopoulos, Meletios A.

Publication type:

Article

B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989585

By:

Sanchez, Larysa;
Dardac, Alexandra;
Madduri, Deepu;
Richard, Shambavi;
Richter, Joshua

Publication type:

Article

Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989579

By:

Candelaria, Myrna;
Dueñas-Gonzalez, Alfonso

Publication type:

Article

Relapsed/refractory multiple myeloma-transformed plasma-cell leukemia successfully treated with daratumumab followed by autologous stem cell transplantation.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620721989578

By:

Yang, Chen-lu;
Jiang, Neng-gang;
Zhang, Li;
Shen, Kai;
Wu, Yu

Publication type:

Article

Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211066070

By:

Al-Samkari, Hanny;
van Beers, Eduard J.

Publication type:

Article

Emicizumab in acquired haemophilia A: about two clinical cases and literature review.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211038193

By:

Hansenne, Amandine;
Hermans, Cedric

Publication type:

Article

Hepatic venoocclusive disease/sinusoidal obstruction syndrome with normal portal vein flow mimicking aggravated chronic hepatic GVHD following inotuzumab ozogamicin salvage therapy: a case report of pathologic-radiologic discrepancy.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211066176

By:

Lee, Joonyeop;
Yoon, Jae-Ho;
Kwag, Daehun;
Lee, Jong-Hyuk;
Kim, Tong Yoon;
Min, Gi June;
Park, Sung-Soo;
Park, Silvia;
Lee, Sung-Eun;
Cho, Byung-Sik;
Eom, Ki-Seong;
Kim, Yoo-Jin;
Kim, Hee-Je;
Min, Chang-Ki;
Cho, Seok-Goo;
Wook Lee, Jong;
Hak Lee, Sung;
Lee, Seok

Publication type:

Article

Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211043748

By:

Park, Silvia;
Kim, Tong Yoon;
Lee, Jong Hyuk;
Lee, Joon yeop;
Min, Gi June;
Park, Sung Soo;
Yahng, Seung-Ah;
Shin, Seung-Hwan;
Yoon, Jae-Ho;
Lee, Sung-Eun;
Cho, Byung Sik;
Eom, Ki-Seong;
Lee, Seok;
Kim, Hee-Je;
Min, Chang-Ki;
Lee, Jong Wook;
Kim, Yoo-Jin

Publication type:

Article

Challenges of biological monitoring in a hemophilia A patient without inhibitors on emicizumab undergoing major orthopedic surgery: a case report.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211040345

By:

Guillaume, Louise;
van Dievoet, Marie-Astrid;
Lambert, Catherine;
Hermans, Cedric

Publication type:

Article

Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211040335

By:

Báez-Gutiérrez, Nerea;
Rodríguez-Ramallo, Héctor;
Moreno, María Antonia-Pérez;
Arboli, Eduardo-Rodriguez;
Abdel-kader Martín, Laila

Publication type:

Article

Bortezomib in autoimmune hemolytic anemia and beyond.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211046428

By:

Pasquale, Raffaella;
Giannotta, Juri Alessandro;
Barcellini, Wilma;
Fattizzo, Bruno

Publication type:

Article

Prophylactic management of patients with von Willebrand disease.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211064064

By:

Franchini, Massimo;
Seidizadeh, Omid;
Mannucci, Pier Mannuccio

Publication type:

Article

Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211063783

By:

Seo, Jeongmin;
Shin, Dong-Yeop;
Koh, Youngil;
Kim, Inho;
Yoon, Sung-Soo;
Min Byun, Ja;
Hong, Junshik

Publication type:

Article

Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211058334

By:

Theodorakakou, Foteini;
Dimopoulos, Meletios A.;
Kastritis, Efstathios

Publication type:

Article

Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211058333

By:

Spindelboeck, Walter;
Halwachs, Bettina;
Bayer, Nadine;
Huber-Krassnitzer, Bianca;
Schulz, Eduard;
Uhl, Barbara;
Gaksch, Lukas;
Hatzl, Stefan;
Bachmayr, Victoria;
Kleissl, Lisa;
Kump, Patrizia;
Deutsch, Alexander;
Stary, Georg;
Greinix, Hildegard;
Gorkiewicz, Gregor;
Högenauer, Christoph;
Neumeister, Peter

Publication type:

Article

Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma.

Published in:

2021

By:

Rampotas, Alexandros;
Sangha, Gina;
Collins, Graham P.

Publication type:

Editorial

Current and emerging treatment options in primary mediastinal B-cell lymphoma.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211048959

By:

Fakhri, Bita;
Ai, Weiyun

Publication type:

Article

A 10-fold and greater increase in D-dimer at admission in COVID-19 patients is highly predictive of pulmonary embolism in a retrospective cohort study.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211048364

By:

Perera, Adrian;
Chowdary, Pratima;
Johnson, James;
Lamb, Lucy;
Drebes, Anja;
Mir, Naheed;
Sood, Tara

Publication type:

Article

Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211048361

By:

Carpenedo, Monica;
Baldacci, Erminia;
Baratè, Claudia;
Borchiellini, Alessandra;
Buccisano, Francesco;
Calvaruso, Giuseppina;
Chiurazzi, Federico;
Fattizzo, Bruno;
Giuffrida, Gaetano;
Rossi, Elena;
Palandri, Francesca;
Scalzulli, Potito Rosario;
Siragusa, Sergio Mario;
Vitucci, Angelantonio;
Zaja, Francesco

Publication type:

Article

Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211039326

By:

Poza, María;
Íñiguez, Rodrigo;
Zamanillo, Irene;
Redondo, Sara;
Alonso, Rafael;
Martínez-López, Joaquín;
Jiménez-Ubieto, Ana

Publication type:

Article

Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211043404

By:

Shallis, Rory M.;
Wang, Rong;
Bewersdorf, Jan P.;
Zeidan, Amer M.;
Davidoff, Amy J.;
Huntington, Scott F.;
Podoltsev, Nikolai A.;
Ma, Xiaomei

Publication type:

Article

Addition of chemotherapy to nivolumab after PD-1 inhibitor failure as bridge to allogeneic stem cell transplantation in classical Hodgkin's lymphoma: report on three cases and literature review.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211038181

By:

Romero, Samuel;
Balaguer-Roselló, Aitana;
Montoro, Juan;
Beneit, Paola;
Martínez, Amelia;
Ruiz, Cristina;
Andreu, Rafael;
Guerreiro, Manuel;
Arnao, Mario;
Montava, Alberto;
Vicente, Ana I.;
Jarque, Isidro;
Sanz, Jaime

Publication type:

Article

Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211035272

By:

Vitkon, Roy;
Netanely, Dan;
Levi, Shai;
Ziv-Baran, Tomer;
Ben-Yzak, Ronit;
Katz, Ben-Zion;
Benyamini, Noam;
Trestman, Svetlana;
Mittelman, Moshe;
Cohen, Yael;
Avivi, Irit

Publication type:

Article

Design of an international investigator-initiated study on MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A (MOTIVATE).

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211032452

By:

Escuriola Ettingshausen, Carmen;
Sidonio Jr., Robert F.

Publication type:

Article

Clinical features of DDX41 mutation-related diseases: a systematic review with individual patient data.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211032433

By:

Wan, Ziqi;
Han, Bing

Publication type:

Article

Case series: MRD negativity assessment using 11 C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myeloma.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211030369

By:

Ngai, Cheong;
Kumar, Shaji;
Chi-lai Ho, Garrett;
Chen, Sirong;
Chim, Chor-sang

Publication type:

Article

Features of indeterminate results of QuantiFERON-TB Gold In-Tube test in patients with haematological malignancies.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211028437

By:

Huang, Chen-Cheng;
Jerry Teng, Chieh-Lin;
Wu, Ming-Feng;
Lee, Ching-Hsiao;
Chen, Hui-Chen;
Huang, Wei-Chang

Publication type:

Article

The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211027463

By:

MacEwan, Joanna P;
Majer, Istvan;
Chou, Jacquelyn W;
Panjabi, Sumeet

Publication type:

Article

The use of tafasitamab in diffuse large B-cell lymphoma.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211027458

By:

Düll, Johannes;
Topp, Max;
Salles, Gilles

Publication type:

Article

CORRIGENDUM to "Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?".

Published in:: 2021
Publication type:: Correction Notice

Natural-killer cell cytotoxicity as a diagnostic and prognostic marker for adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective phase II observational study.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211020544

By:

Oh, Eun-Jee;
Yoon, Jae-Ho;
Park, Ki Hyun;
Bae, Hyun Joo;
Yun, So Jeong;
Min, Gi June;
Park, Sung-Soo;
Park, Silvia;
Lee, Sung-Eun;
Cho, Byung-Sik;
Eom, Ki-Seong;
Kim, Yoo-Jin;
Lee, Seok;
Kim, Hee-Je;
Min, Chang-Ki;
Cho, Seok-Goo;
Han, Kyungja;
Lee, Jong Wook

Publication type:

Article

The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211019622

By:

Oriol, Albert;
Abril, Laura;
Torrent, Anna;
Ibarra, Gladys;
Ribera, Josep-Maria

Publication type:

Article

The role of carfilzomib in relapsed/refractory multiple myeloma.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211019612

By:

Yee, Andrew J.

Publication type:

Article

Maintenance therapy for untreated diffuse large B-cell lymphoma: a systematic review and network meta-analysis.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211018894

By:

Yuan, Ting;
Zhang, Feng;
Yao, Qingmin;
Liu, Yanxia;
Zhu, Xiaojuan;
Chen, Peng

Publication type:

Article

Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211018042

By:

Gerb, Jesse;
Strauss, William;
Derman, Richard;
Short, Vanessa;
Mendelson, Ben;
Bahrain, Huzefa;
Auerbach, Michael

Publication type:

Article

Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211010875

By:

Cooper, Nichola;
Altomare, Ivy;
Thomas, Mark R.;
Nicolson, Phillip L. R.;
Watson, Steve P.;
Markovtsov, Vadim;
Todd, Leslie K.;
Masuda, Esteban;
Bussel, James B.

Publication type:

Article

A novel treatment regimen of granulocyte colony-stimulating factor combined with ultra-low-dose decitabine and low-dose cytarabine in older patients with acute myeloid leukemia and myelodysplastic syndromes.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211009334

By:

Zhu, Huan;
Yang, Bin;
Liu, Jia;
Wang, Biao;
Wu, Yicun;
Zheng, Zhuojun;
Ling, Yun

Publication type:

Article

The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphoma.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211017788

By:

Sandoval-Sus, Jose;
Chavez, Julio C.

Publication type:

Article

Treosulfan-based conditioning for inborn errors of immunity.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211013985

By:

Slatter, Mary A.;
Gennery, Andrew R.

Publication type:

Article

Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211012985

By:

Park, Songyi;
Shin, Dong-Yeop;
Hong, Junshik;
Kim, Inho;
Koh, Youngil;
Byun, Ja Min;
Yoon, Sung-Soo

Publication type:

Article

Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211011353

By:

Gruden, Gabriella;
Beggiato, Eloise;
Camerino, Enrica;
Capriotti, Serena;
Canepa, Silvia;
Scandella, Michela;
Avolio, Maria;
Pittalunga, Fabrizia;
Barutta, Federica;
Durazzo, Marilena

Publication type:

Article

The role of tazemetostat in relapsed/refractory follicular lymphoma.

Published in:

Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211015882

By:

von Keudell, Gottfried;
Salles, Gilles

Publication type:

Article